Overview Investment Highlights FAQ Stock Quote News Releases SEC Filings Analyst Coverage Webcasts CFMI (PPT) Presentation Standard & Poor’s Email Alerts & IR Contact
Senior TriPoint Global Research analyst Stanley Ng presents an Initial Research Report, with a Market Outperform Rating on China Pharmaceuticals, Inc. The report details the relative low valuations vis-à-vis peer companies.
Research Note Issued May 9, 2011, click here
For the 32-page Initial Research Report July 9, 2010, click here
Home | Profile | Management | Products | Investor Relations | Contact | Site Map | Privacy Policy | Disclaimer | FAQ Copyright © 2011 China Pharmaceuticals, Inc. All rights reserved. Tel: 86-29-8406-7215 OTCBB Listed CFMI
